Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.

Janku, Filip

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. [electronic resource] - Oncotarget May 2014 - 3012-22 p. digital

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural

1949-2553

10.18632/oncotarget.1687 doi


Aged
Antineoplastic Agents--therapeutic use
Carcinoma, Hepatocellular--drug therapy
Female
High-Throughput Nucleotide Sequencing
Humans
Liver Neoplasms--drug therapy
Male
Middle Aged
Molecular Targeted Therapy
Phosphatidylinositol 3-Kinases--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Signal Transduction--physiology
TOR Serine-Threonine Kinases--metabolism